Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.1277
Nov 16 • 7:20 AM ET Dollar change+0.0006 Percentage change(0.47%)
Nov 12, 6:15 PMVivoSim reported a fiscal second-quarter loss of $475,000, or 3 cents per share, on revenue of $51,000.
Index
-
Market Cap
2.59M
Enterprise Value
-5.46M
Income
-10.27M
Sales
0.14M
Book/sh
0.40
Cash/sh
0.42
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
15
IPO
Feb 14, 2012
P/E
-
Forward P/E
-
PEG
-
P/S
18.52
P/B
0.32
P/C
0.30
P/FCF
-
EV/EBITDA
-
EV/Sales
-38.98
Quick Ratio
3.49
Current Ratio
3.50
Debt/Eq
0.07
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-3.52
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS past 3/5Y
39.18% 28.81%
Sales past 3/5Y
-29.26% -
EPS Y/Y TTM
-344.17%
Sales Y/Y TTM
-3.57%
EPS Q/Q
97.04%
Sales Q/Q
82.14%
Earnings
-
EPS/Sales Surpr.
46.15% -26.83%
Insider Own
16.62%
Insider Trans
0.30%
Inst Own
11.23%
Inst Trans
0.72%
ROA
-104.72%
ROE
-143.54%
ROIC
-141.78%
Gross Margin
-67.41%
Oper. Margin
-8897.78%
Profit Margin
-7605.93%
SMA20
-13.97%
SMA50
-33.23%
SMA200
-86.86%
Trades
Shs Outstand
18.07M
Shs Float
13.83M
52W High
3.40 -96.24%
52W Low
0.12 2.98%
Volatility
20.43% 12.63%
ATR (14)
0.02
RSI (14)
36.27
Beta
1.57
Rel Volume
0.15
Avg Volume
1.01M
Volume
7,518
Perf Week
-10.92%
Perf Month
-18.61%
Perf Quarter
-54.16%
Perf Half Y
-89.94%
Perf YTD
-92.94%
Perf Year
-94.12%
Perf 3Y
-99.22%
Perf 5Y
-99.80%
Perf 10Y
-99.98%
Prev Close
0.13
Price
0.13
Change %
0.47%
Consensus
Hold
Avg. Price Target
$64.80
Implied Upside
+50,643.9%
Analysts5incl. previous ratings
Rating Distribution3 Buy · 2 Hold · 0 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
Dec 13, 2018Initiated
HH.C. Wainwright
Buy$2.50+1,857.7%
Nov 10, 2017Downgrade
RJF logoRRaymond James
Outperform → Mkt Perform
Jan 25, 2017Initiated
RJF logoRRaymond James
Outperform
Aug 11, 2015Downgrade
CCantor Fitzgerald
Buy → Hold
Jun 29, 2015Initiated
PPiper Jaffray
Overweight$5+3,815.4%
Jun 29, 2015Initiated
JEF logoJJefferies
Buy$5+3,815.4%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lialin Tony SergeChief Commercial OfficerAug 31 '26Buy0.2810,0002,80410,000Sep 01 04:01 PM
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Executive Chairman & Corporate SecretaryMr. Keith E. Murphy
PresidentMr. Norman Staskey
Ph.D.Dr. Amar A. Sethi M.D.
Chief Commercial OfficerMr. Tony Lialin